Neil J. Clendeninn
Neil J. Clendeninn publishes mostly in Oncology, Molecular Biology and Infectious Diseases, on topics such as Lung Cancer Research Studies, Melanoma and MAPK Pathways and HIV Research and Treatment.
- World rank
- #2,080,414 of 7,710,434 ranked researchers
- Rank in United States
- #628,668 of 1,627,098
- Works
- 74
- Citations
- 2.8k
- Citations per work
- 37.2
What does Neil J. Clendeninn research?
Neil J. Clendeninn's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3345.1%
- Health Sciences2837.4%
- Medicine2837.4%
- Life Sciences1317.5%
- 1Oncology21% of their works
- 2Molecular Biology12% of their works
- 3Infectious Diseases6% of their works
- 4Surgery6% of their works
- 5Cancer Research5% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
Which keywords describe Neil J. Clendeninn's research?
The keywords of their largest research topics: Chemotherapy, Antiretroviral Therapy, Cetuximab, Clinical Trials, Immune Response, Targeted Therapy, Genomic Profiles and Small-Cell Lung Cancer.
- Preexposure Prophylaxis
- HIV Infection
- Drug Resistance
- Oropharyngeal Cancer
- KRAS Mutations
- HIV
- BRAF gene
- Small-Cell Lung Cancer
- Targeted Therapy
- Clinical Trials
- Antiretroviral Therapy
- Chemotherapy
- Cetuximab
- Immune Response
- Genomic Profiles
- AIDS
- Fluorouracil
- Human Papillomavirus
- MAP Kinase
- ALK Inhibitors
- EGFR Mutations
- HIV Transmission
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy163 topics
- Antiretroviral Therapy133 topics
- Cetuximab102 topics
- Clinical Trials102 topics
- Immune Response102 topics
- Targeted Therapy102 topics
- Genomic Profiles61 topic
- Small-Cell Lung Cancer61 topic
- AIDS51 topic
- BRAF gene51 topic
- Fluorouracil51 topic
- HIV51 topic
- Human Papillomavirus51 topic
- KRAS Mutations51 topic
- MAP Kinase51 topic
- Oropharyngeal Cancer51 topic
- ALK Inhibitors41 topic
- Drug Resistance41 topic
- EGFR Mutations41 topic
- HIV Infection41 topic
- HIV Transmission41 topic
- Preexposure Prophylaxis41 topic
Where does Neil J. Clendeninn work?
Neil J. Clendeninn's main affiliation in the publication record is Burroughs Wellcome Fund, United States.
How many publications and citations does Neil J. Clendeninn have?
OpenAlex counts 74 works and 2,750 citations for Neil J. Clendeninn, an h-index of 22, ranking #2,080,414 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Neil J. Clendeninn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.